Results
1442
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,442 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$30.45 | -2.4% | 89.1% | US$5.6b | US$29.83 | PS26.1x | E60.9% | n/a | Semiconductors | ||
GIG | NOK 29.80 | 0.3% | 10.6% | NOK 4.0b | NOK 45.03 | PE18.6x | E37.4% | n/a | Consumer Services | ||
CALTX | SEK 206.40 | 0.4% | 142.5% | SEK 11.2b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €6.66 | -2.1% | 68.4% | €100.2m | €6.30 | PS16.6x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.49 | -2.6% | 0% | SEK 404.0m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
VOW | NOK 7.64 | 10.9% | -51.0% | NOK 869.7m | NOK 11.00 | PB2.2x | E97.7% | 0% | Commercial Services | ||
A441270 | ₩9,110.00 | -3.3% | 7.2% | ₩336.8b | ₩11,500.00 | PE21.6x | E36.4% | n/a | Tech | ||
CUV | AU$15.24 | 1.2% | -17.2% | AU$769.2m | AU$30.33 | PE25.3x | E26.8% | 0.3% | Pharmaceuticals & Biotech | ||
EH | US$14.59 | -2.9% | -21.3% | US$966.4m | US$24.98 | PS42.7x | E74.3% | n/a | Capital Goods | ||
688408 | CN¥66.37 | 10.9% | 38.4% | CN¥12.6b | CN¥66.22 | PE28.9x | E25.4% | 0.9% | Capital Goods | ||
A204620 | ₩4,035.00 | -1.2% | 19.4% | ₩229.1b | ₩7,100.00 | PS2.1x | E72.4% | n/a | Commercial Services | ||
A179900 | ₩31,800.00 | 8.3% | 44.9% | ₩503.1b | ₩60,000.00 | PS25x | E122.7% | 0% | Tech | ||
A178320 | ₩29,200.00 | -15.2% | 60.4% | ₩1.6t | ₩39,333.33 | PE151.2x | E58.7% | 0% | Tech | ||
A067310 | ₩20,150.00 | 1.3% | -4.7% | ₩955.6b | ₩31,666.67 | PB3.2x | E96.3% | 0.2% | Semiconductors | ||
CTT | AU$1.41 | -1.1% | -58.8% | AU$588.6m | AU$3.12 | PE27.7x | E26.7% | n/a | Retail | ||
4480 | JP¥4,400.00 | 13.1% | -15.5% | JP¥144.5b | JP¥5,800.00 | PE53.4x | E28.7% | n/a | Healthcare | ||
PLT | AU$0.71 | -2.1% | 81.0% | AU$132.4m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
300181 | CN¥14.52 | -6.6% | 27.4% | CN¥10.0b | n/a | PE23.8x | E22.3% | 3.1% | Pharmaceuticals & Biotech | ||
YGG | ฿1.28 | -16.9% | -83.0% | ฿770.6m | ฿10.75 | PE11.2x | E33.5% | 20.9% | Media | ||
ACI | ₹701.15 | -2.2% | 32.3% | ₹86.7b | ₹757.20 | PE27.1x | E28.9% | 0.4% | Materials | ||
517522 | ₹588.80 | -2.4% | -29.0% | ₹31.0b | ₹772.00 | PE41.6x | E33.5% | 0.3% | Materials | ||
505283 | ₹1,356.90 | -2.0% | 109.4% | ₹86.5b | ₹1,705.00 | PE66x | E29.8% | 0.5% | Capital Goods | ||
ATAT | US$17.76 | -6.0% | -8.7% | US$2.4b | US$27.17 | PE18.2x | E22.1% | 0.8% | Consumer Services | ||
YUBICO | SEK 259.00 | 7.5% | 159.0% | SEK 22.3b | SEK 265.00 | PE134.7x | E43.8% | n/a | Software |